Evidence map›Paper›PMID 41857113›Full record

ArticleScientific reports2026

Population genetic variation characterised through serial independent pool-seq: the Cyprus Genome Project.

Athos Antoniades, Jianxiang Chi, Cameron Brown, Paris Vogazianos, Emily Charalambous, Dimitris Vrachnos, Aristos Aristodimou, Andri Miltiadous, Andri Papaloizou, Anita Koumouli and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Athos Antoniades *Stremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus. Athos.antoniades@stremble.com.
Jianxiang Chi *The Centre for the Study of Heamatological and other Malignancies, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Cameron BrownStremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus.
Paris VogazianosStremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus.
Emily CharalambousStremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus.
Dimitris VrachnosStremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus.
Aristos AristodimouStremble Ventures Ltd, Ko 8 Germasogeia, Limassol, 4045, Cyprus.
Andri MiltiadousKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Andri PapaloizouKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Anita KoumouliKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Petroula GerasimouKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Yiannos KyprianouKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.
Paul CosteasKaraiskakio Foundation, 15, Nicandrou Papamina Avenue, Nicosia, 2032, Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cyprus Genome Project characterizes the genetic landscape of the Cypriot population to address the lack of population-specific data in global repositories. We employed a serial independent pool-sequencing (pool-seq) strategy to sequence DNA from 10,000 healthy bone marrow donors, randomized into 10 independent biological replicates. This study design was selected to leverage specific operational and statistical advantages. Operationally, the method enables the processing of a large cohort that would be cost-prohibitive using individual sequencing. Statistically, the use of 10 independent biological replicates allowed for the differentiation of true low-frequency variants from sequencing artifacts. Furthermore, this design enabled the calculation of empirical confidence intervals for variant frequencies. We utilized both Whole Exome Sequencing and a targeted gene panel (813 genes) to maximize read depth and sensitivity. The study identified over 4 million variants, including > 100,000 variants absent from the gnomAD v4.1 and ClinVar databases. Validation against published clinical cohorts confirmed high concordance (r > 0.92). The results highlight significant differences between local and global allele frequencies, including pathogenic variants that are common in Cyprus but rare globally. The results, including an interactive genome map with full annotations from gnomAD v4.1 and ClinVar, are publicly accessible at www.cyprusgenome.org , with the aim of advancing healthcare and facilitating future clinical research.

Indexed as

Genetics, PopulationGenetic VariationGenome, HumanCyprusExome SequencingGene FrequencyHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single NucleotideSequence Analysis, DNA

Identifiers

PMID41857113
PMCPMC13139603

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.